Metabotropic Glutamate Receptors as Targets for Analgesia: Antagonism, Activation, and Allosteric Modulation

Author(s): Michael C. Montana, Robert W. Gereau.

Journal Name: Current Pharmaceutical Biotechnology

Volume 12 , Issue 10 , 2011

Become EABM
Become Reviewer


The metabotropic glutamate receptors (mGluRs) are expressed pre- and post-synaptically throughout the nervous system where they serve as modulators of synaptic transmission and neuronal excitability. Activation of mGluRs can be pro- or anti-nociceptive, depending on their anatomic location and the signaling cascades to which they couple. Antagonists of Group I mGluRs and agonists of Group II and III mGluRs have shown therapeutic promise in animal pain models. This article reviews the potential therapeutic utility of several agents that act predominantly via mGluRs, specifically focusing on their analgesic efficacy and discussing possible off-target effects. Glutamate, the primary excitatory neurotransmitter in the vertebrate nervous system, mediates its effects via activation of two main classes of receptors: ligand-gated ion channels known as ionotropic receptors and G-protein coupled metabotropic receptors. Antagonists of ionotropic glutamate receptors, such as ketamine, have robust analgesic properties; however, their analgesic utility is limited to monitored clinical settings due to the potential for psychomimetic effects.

Keywords: Pain, analgesia, sensitization, mGluR, metabotropic glutamate receptors (mGluRs), synaptic transmission, neuronal excitability, anti-nociceptive, potential therapeutic utility, their analgesic efficacy, excitatory neurotransmitter, G-protein coupled metabotropic receptors, robust analgesic properties, psychomimetic effects

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [1681 - 1688]
Pages: 8
DOI: 10.2174/138920111798357438
Price: $58

Article Metrics

PDF: 10